| About the author: |
N. V. Kuzminova, A. V. Ivankova, S. E. Lozinsky, I. I. Knyazkova, V. P. Ivanov, O. M. Kulchytska, Yu. L. Shkarivsky |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
156 patients with stage II essential hypertension were examined, among them, 124 had frequent symptomatic extrasystole and 32 patients did not have any heart rhythm disorders. Another 30 healthy persons were included in the control group. Complete clinical, laboratory and instrumental examinations were applied to all study participants, including daily blood pressure monitoring and cystatin C serum concentration. It was found that the level of cystatin C was significantly higher in hypertensive patients compared to controls (р<0.001). In turn, in the presence of extrasystoles, the mean cystatin C was significantly higher than in patients without extrasystoles (p<0.05). The highest level of cystatin C was noticed in patients with essential hypertension and ventricular extrasystole. It was significantly different from the patients with extrasystole of supraventricular origin (p<0.05) and patients without arrhythmias (p<0.001) or healthy individuals (p<0.001). Also, higher values of blood pressure and a relatively high level of serum cystatin C were found in patients with hypertension, which allows us to suspect the common pathophysiological mechanisms of an increase in the cystatin C level, values of blood pressure and the occurrence of frequent extrasystoles (especially of the ventricular origin). |
| Tags |
hypertension,cystatin C,daily blood pressure monitoring,extrasystole |
| Bibliography |
- Filler G, Rodriguez Cuellar C, Medeiros M. Overcoming the limitations of glomerular filtration rate estimation by using a novel rapid bedside measurement? Ann Transl Med. 2018; 6 (15): 312. https://doi.org/10.21037/atm.2018.06.51
- Hoogendijk MG, Geczy T, Yap S, Szili-Torok T. Pathophysiological mechanism of premature ventricular complexes. Front Physiol. 2020; 11: 406. https://doi.org/10.3389/fphys.2020.00406
- Ivanytskyi IV, Katerenchuk OI, Nekrasov KA, Ivanytska TA. Left ventricular noncompaction associated with genetic disturbance of folic acid metabolism. Kardiol Pol. 2019; 77 (12): 1196–1197. https://doi.org/10.33963/KP.15024
- Jin S, Xu J, Shen G, Gu P. Predictive value of circulating cystatin C level in patients with acute coronary syndrome: a meta-analysis. Scand J Clin Lab Invest. 2021; 81 (1): 1–7. https://doi.org/10.1080/00365513.2020.1846212
- Kuzminova NV, Ivankova AV, Ivanov VP, Lozinsky SE. Diagnostic and prognostic value of cystatin C as an early marker of renal dysfunction in patients with cardiovascular pathology. Likarska sprava. 2018; 7-8: 17–23.
- Kuzminova NV, Ivankova AV, Lozinsky SE, Knyazkova II, Kulchytska OM, Gavriluk AO, Shkarivskyi YuL. Changes of apelin-13 and cystatin C levels and metabolic profile in patients with hypertension and frequent ventricular extrasystole. Word of medicine and biology. 2022; 1 (79): 85–90. https://doi.org/10.26724/2079-8334-2022-1-79-85-90
- Liu HY, Wu JY, Chung CP, Lee IH, Lin CJ, Lin CJ. [et al.] Premature Atrial Contractions and Their Association with Stroke Features and Outcome. J Stroke Cerebrovasc Dis. 2020; 29 (10): 105118. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020
- Marcus GM. Evaluation and Management of Premature Ventricular Complexes. Circulation. 2020; 141 (17): 1404–18. https://doi.org/10.1161/CIRCULATIONAHA.119.042434
- Rothenbacher D, Rehm M, Iacoviello L, Costanzo S, Tunstall-Pedoe H, Belch JJF. et al. Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project. BMC Medicine. 2020; 18 (1): 13. https://doi.org/10.1186/s12916-020-01776-7
- Sun Y, Lu Q, Cheng B, Tao X. Prognostic value of cystatin C in patients with acute coronary syndrome: A systematic review and meta-analysis. Eur. J. Clin. Invest. 2021; 51 (3): e13440. https://doi.org/10.1111/eci.13440
- Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D. et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020; 75: 1334–57. https://doi.org/10.1161/HYPERTENSIONAHA. 120.15026
- Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M. et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39 (33): 3021–3104. https://doi.org/10.1093/eurheartj/ehy339
- Yang F, Liu P, Huang S, Liu X, Gao X, Liu C, et al. Serum cystatin C was a marker of poststroke fatigue in hypertensive intracerebral hemorrhage. Brain Behav. 2021; 11 (2): e01969. https://doi.org/10.1002/brb3.1969
- Zhu Z, Zhong C, Xu T, Wang A, Peng Y, Xu T. et al. Prognostic significance of serum cystatin C in acute ischemic stroke patients according to lipid component levels. Atherosclerosis. 2018; 274: 146–51. https://doi.org/10.1016/j.atherosclerosis. 2018.05.015
- Zinellu A, Mangoni AA. Cystatin C, COVID-19 severity and mortality: a systematic review and meta-analysis. J Nephrol. 2022; 35 (1): 59–68. https://doi.org/10.1007/s40620-021-01139-2
|
| Publication of the article |
«World of Medicine and Biology» №1(83), 2023 year, 116-120 pages, index UDK 616.12-008.331.1:616.12-008.318.4 |
| DOI |
10.26724/2079-8334-2023-1-83-116-120 |
